Epigenesis Pharmaceuticals, Inc.

Cranbury, NJ 08512

SBIR Award Summary

Total Number of Awards 2
Total Value of Awards $0.0
First Award Date 09/30/97
Most Recent Award Date 09/30/99

Key Personnel

Last Name Name Awards Contact
Nyce Jonathan W Nyce 2

2 Awards Won

Phase 2 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/99 - 08/31/00

DESCRIPTION: (Adapted from the Applicant's Abstract): This is a Phase II study of a new asthma treatment. The investigators have developed a respirable antisense oligonucleotide, EPI 2010, which targets the adenosine A1 receptor. They have shown that it has anti-bronchoconstrictor and anti-inflammatory actions...

Phase 1 SBIR

Agency: Department of Health & Human Services
Topic:
Budget: 09/30/97 - 06/29/98

The broad, long-term objective of this research is to evaluate a specific phosphorothioate antisense oligodeoxynucleotide targeting the adenosine A1 receptor as an effective asthma therapeutic. Asthma accounts for 1% of all health care expenditures in the United States. Ten percent of adult Am...